SB Global Advisers’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$14.3M Hold
2022
Q3
$24.7M Hold
2022
Q2
$18.6M Hold
2022
Q1
$61.1M Hold
2021
Q4
$75M Buy